Skip to content

Imunon, Inc.: 10-K filed 2013-03-18

What Imunon, Inc. reported in its annual report filed 2013-03-18 (fiscal FY 2012): 36 published measures, 94 facts as tagged in accession 0001437749-13-003088.

This filing

Form
10-K (annual report)
Filed
2013-03-18
Fiscal period
fiscal FY 2012
Accession
0001437749-13-003088 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Imunon, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3125,358,918USD
At 2011-12-3132,649,459USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-3113,397,060USD
At 2011-12-316,455,891USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3111,961,858USD
At 2011-12-3126,193,568USD
At 2010-12-31-4,575,525USD
At 2009-12-3110,035,794USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3114,991,488USD
At 2011-12-3120,145,854USD
At 2010-12-311,138,916USD
At 2009-12-316,923,476USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-12-01 to 2012-12-31-26,568,382USD31
2012-01-01 to 2012-12-31-26,568,382USD366
2011-01-01 to 2011-12-31-23,222,678USD365
2010-01-01 to 2010-12-31-18,818,435USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-22,329,593USD366
2011-01-01 to 2011-12-31-22,742,437USD365
2010-01-01 to 2010-12-31-13,367,389USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-31613,390USD366
2011-01-01 to 2011-12-31573,406USD365
2010-01-01 to 2010-12-316,745USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-3115,518,984USD366
2011-01-01 to 2011-12-3152,836,463USD365
2010-01-01 to 2010-12-312,376,204USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,656,243USD366
2011-01-01 to 2011-12-31-11,087,088USD365
2010-01-01 to 2010-12-315,206,625USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-150,876,770USD
At 2011-12-31-124,221,823USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-311,114,621USD
At 2011-12-31782,720USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,084,326USD366
2011-01-01 to 2011-12-311,036,337USD365
2010-01-01 to 2010-12-311,295,382USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-22,142,717USD366
2011-01-01 to 2011-12-31-23,018,769USD365
2010-01-01 to 2010-12-31-19,637,427USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3123,648,984USD
At 2011-12-3131,508,485USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-31359,413USD366
2011-01-01 to 2011-12-31501,855USD365
2010-01-01 to 2010-12-3131,517USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-315,005,202USD
At 2011-12-316,152,424USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-312,339,768USD
At 2011-12-314,010,203USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-12-3128,125USD
At 2011-12-3135,625USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-3122,142,717USD366
2011-01-01 to 2011-12-3125,018,769USD365
2010-01-01 to 2010-12-3119,637,427USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-3115,770,166USD366
2011-01-01 to 2011-12-3119,863,836USD365
2010-01-01 to 2010-12-3114,714,460USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3137,302,785shares
At 2011-12-3133,186,325shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-31-126,607USD
At 2011-12-31-276,700USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-12-315,000,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-312,039,582USD
At 2011-12-311,426,192USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31924,961USD
At 2011-12-31643,472USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31595,313USD
At 2011-12-31358,254USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31446,779USD
At 2011-12-3165,467USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-26,418,289USD366
2011-01-01 to 2011-12-31-23,361,441USD365
2010-01-01 to 2010-12-31-18,904,975USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,372,551USD366
2011-01-01 to 2011-12-315,154,933USD365
2010-01-01 to 2010-12-314,922,967USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-31281,500USD366
2011-01-01 to 2011-12-31169,000USD365
2010-01-01 to 2010-12-31165,000USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31281,489USD366
2011-01-01 to 2011-12-31169,358USD365
2010-01-01 to 2010-12-31165,480USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-12-317,500USD366
2011-01-01 to 2011-12-317,500USD365
2010-01-01 to 2010-12-317,500USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,040USD366
2011-01-01 to 2011-12-3142,149USD365
2010-01-01 to 2010-12-31244,460USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-4,425,665USD366
2011-01-01 to 2011-12-31-203,909USD365
2010-01-01 to 2010-12-31818,992USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-12-3148,082,025USD365
2010-01-01 to 2010-12-312,484,536USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,344,379USD366
2011-01-01 to 2011-12-31-538,383USD365
2010-01-01 to 2010-12-312,357,629USD365

Inspect the source

Entity
Imunon, Inc. / CIK 0000749647
Captured
2026-09-19T15:01:50.763Z
SEC response SHA-256
cf2e46071525a607b4d539753f5129368297f1e667d6fa4f8829e76132e7a85a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000749647.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))